Read, J S <br/><br/>
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.  [electronic resource] 

 -  HIV medicine  Nov 2008 
 - 875-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1468-1293 
<br/><br/><label>Standard No.: </label>10.1111/j.1468-1293.2008.00640.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Area Under Curve<br/>CD4 Lymphocyte Count<br/>Drug Administration Schedule<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1<br/>Humans<br/>Infant, Newborn<br/>Nelfinavir--administration & dosage<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Puerperal Infection--drug therapy<br/>RNA, Viral<br/>Viral Load<br/>Young Adult